Cytokinetics, Inc. (CYTK) to Announce First Quarter Results on April 30, 2013
4/17/2013 9:13:47 AM
More...
|
Cytokinetics, Inc. (CYTK) Reports Second Quarter 2012 Financial Results
8/1/2012 8:40:39 AM
More...
|
Cytokinetics, Inc. (CYTK) Announces Heart Failure Program Update
7/26/2012 8:58:08 AM
More...
|
Cytokinetics, Inc. (CYTK) to Announce Second Quarter Results on July 31, 2012
7/25/2012 9:08:17 AM
More...
|
Cytokinetics, Inc. (CYTK) to Present at 7th Annual JMP Securities Healthcare Conference
7/6/2012 9:10:22 AM
More...
|
Cytokinetics, Inc. (CYTK) Announces Proposed Public Offerings of Common Stock and Warrants and Series B Convertible Preferred Stock and Warrants
6/20/2012 8:51:44 AM
More...
|
Cytokinetics, Inc. (CYTK) Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
6/20/2012 8:50:56 AM
More...
|
Cytokinetics, Inc. (CYTK) Nabs $60 Million Financing
6/20/2012 7:38:58 AM
More...
|
Cytokinetics, Inc. (CYTK) Announces Publication of Phase II Evidence of Effect Study of CK-2017357 in the Journal Amyotrophic Lateral Sclerosis
6/12/2012 8:50:19 AM
More...
|
Cytokinetics, Inc. (CYTK) Announces Opening of Second Cohort in Phase IIb Clinical Trial of Intravenous Omecamtiv Mecarbil in Patients With Acute Heart Failure
5/24/2012 8:51:26 AM
More...
|
|